Press Releases
March 1, 2023
Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
February 13, 2023
Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards
January 26, 2023
Panbela Announces Pricing of Approximately $15 Million Public Offering
January 19, 2023
Panbela Announces Adoption of Commission Implementing Decision from the EMA for the Orphan Designation of Ivospemin (SBP-101)
Panbela Announces Adoption of Commission Implementing Decision from the EMA for the Orphan Designation of Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
January 12, 2023
Panbela Announces 1-for-40 Reverse Stock Split effective 1/13/23
January 11, 2023
Panbela Starts Phase II Trial of CPP-1X-T for Recent Onset Type I Diabetes, in Collaboration with Indiana University School of Medicine and JDRF
December 14, 2022
Panbela Receives Positive EMA Opinion on Orphan Designation for Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
November 28, 2022
Panbela Announces First Patients Enrolled in Europe for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
November 10, 2022
Panbela Provides Business Update and Reports Q3 2022 Financial Results
October 31, 2022
Panbela Schedules Conference Call on Nov 10, 2022 to Report 2022 Third Quarter Financial Results
November 10, 2022, 4:30 PM Eastern Time
Participant Numbers
Toll Free: 877-545-0523 / International: 973-528-0016
Participant Access Code: 598956
Webcast Link: https://www.webcaster4.com/Webcast/Page/2556/46946
Conference Call Replay Information
Replay Number:
Toll Free: 877-481-4010 / International: 919-882-2331
Replay Passcode: 46946
Webcast Replay: https://www.webcaster4.com/Webcast/Page/2556/46946
Events & Presentations